Cardiol Therapeutics (CRDL) Non-Current Assets (2020 - 2026)

Cardiol Therapeutics' Non-Current Assets history runs 7 years deep, the most recent figure standing at $101337.0 for Q1 2026.

• Quarterly Non-Current Assets fell 20.34% year-over-year to $101337.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $406471.7 (down 46.3% YoY) and the FY2025 annual result came in at $84682.9, down 39.52% from the prior year.
• Non-Current Assets was $101337.0 for Q1 2026 at Cardiol Therapeutics, up from $84682.9 in the prior quarter.
• Across five years, Non-Current Assets topped out at $550723.8 in Q1 2022 and bottomed at $84682.9 in Q4 2025.
• A 5-year average of $302742.1 and a median of $363081.1 in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2023 — Non-Current Assets slipped 2.27% — and 2024, when it slumped 65.18%.
• Cardiol Therapeutics' Non-Current Assets stood at $435052.6 in 2022, then slipped by 7.58% to $402096.5 in 2023, then slumped by 65.18% to $140014.4 in 2024, then sank by 39.52% to $84682.9 in 2025, then rose by 19.67% to $101337.0 in 2026.
• Business Quant data shows CRDL's Non-Current Assets at $101337.0 in Q1 2026, $84682.9 in Q4 2025, and $102441.7 in Q3 2025.